Evidence map›Paper›PMID 34626431›Full record

Trial reportAmerican journal of hematology2021

Exercise-induced changes of vital signs in adults with sickle cell disease.

Solomon Johnson, Victor R Gordeuk, Roberto Machado, J Simon R Gibbs, Mariana Hildesheim, Jane A Little, Gregory J Kato, Mark T Gladwin, Mehdi Nouraie

Open access · bronzeAbstract readClinical TrialMulticenter Study
In one paragraph

Trial report in American journal of hematology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

Solomon JohnsonDepartment of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.ORCID 0000-0002-2380-9203
Victor R GordeukDepartment of Medicine, University of Illinois at Chicago, Chicago, Illinois, USA.ORCID 0000-0003-4725-7295
Roberto MachadoDepartment of Medicine, Indiana University, Bloomington, Indiana, USA.
J Simon R GibbsNational Heart & Lung Institute, Imperial College London, London, UK.
Mariana HildesheimDepartment of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Jane A LittleDepartment of Medicine, University of North Carolina, Chapel Hill, North Carolina, USA.
Gregory J KatoDepartment of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.ORCID 0000-0003-4465-3217
Mark T GladwinDepartment of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Mehdi NouraieDepartment of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.ORCID 0000-0001-7465-0581
University of Pittsburgh · USImperial College London · GBIndiana University Bloomington · USUniversity of Illinois Chicago · USUniversity of North Carolina at Chapel Hill · US

Funding

Vascular Subphenotypes of Lung DiseaseP01HL103455 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI FREEMAN, BRUCE ALAN · 2011 to 2020
$26.1M
NHLBI NIH HHS P01 HL103455
6 · The paper itself

Abstract

The six-minute walk test (6MWT) has been used in patients with sickle cell disease (SCD), in conjunction with tricuspid regurgitant velocity (TRV) and plasma N-terminal pro-brain natriuretic peptide (NT-pro BNP), to assess risk of having pulmonary hypertension. Exercise-induced vital sign changes (VSCs) are predictors of clinical outcomes in other diseases. In this study, we assess the predictors and prognostic value of 6MWT VSC in adult SCD patients. Data from a multinational study of SCD patients (Treatment of Pulmonary Hypertension with Sildenafil: walk-PHaSST) were used to calculate the 6MWT VSC. Predictors of VSC were identified by a multivariable analysis, and a survival analysis was conducted by the Cox proportional hazard method. An increase in heart rate was observed in 90% of the 630 SCD adults, 77% of patients had an increase in systolic blood pressure (SBP), and 50% of patients had a decrease in oxygen saturation. TRV (odds ratio [OR] = 1.82, p = .020), absolute reticulocyte count (OR = 1.03, p < .001), and hemoglobin (OR = 0.99, p = .035) predicted oxygen desaturation ≥ 3% during the 6MWT. In the adjusted analysis, SBP increase during the 6MWT was associated with improved survival (hazards ratio = 0.3, 95% confidence interval: 0.1-0.8). Increases in heart rate and blood pressure, as well as oxygen desaturation, are common in adults with SCD during the 6MWT. VSC is associated with markers of anemia and TRV and can be used for risk stratification. Any increase in SBP during the 6MWT was associated with improved survival and may be indicative of a patient's ability to increase stroke volume.

Indexed as

Exercise TherapyAdultAnemia, Sickle CellFemaleHumansHypertension, PulmonaryMaleSurvival AnalysisVital SignsWalking

Identifiers

PMID34626431
PMCPMC8616821
OpenAlexW3201926621

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.